Journal
PEDIATRIC BLOOD & CANCER
Volume 69, Issue 6, Pages -Publisher
WILEY
DOI: 10.1002/pbc.29695
Keywords
pain management; regional anesthesia; sickle cell disease
Categories
Funding
- NIH [K23-HL148548-01A1]
Ask authors/readers for more resources
Placing CPNB for analgesia in pediatric SCD patients with opioid-refractory upper-extremity VOC can reduce opioid consumption, improve pain scores, and decrease length of hospitalization.
Pain management is challenging for patients with sickle cell disease (SCD) who present in vaso-occlusive crisis (VOC). Opioid therapy is highly effective, nevertheless undesirable side effects can hinder their effectiveness. Regional anesthesia with deposition of perineural anesthetic offers nociceptive blockade, local vasodilatation, and reduces the inflammatory response. Among pediatric patients, continuous peripheral nerve block (CPNB) for perioperative adjunctive analgesia is safe. Herein, we describe the trajectory of a cohort of pediatric SCD patients with opioid-refractory upper-extremity VOC following placement of CPNBs for analgesia; highlighting reduced opioid consumption, improved pain scores, and decreased length of hospitalization.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available